Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts, Ian Bruce, University of Manchester, UK, and Julia Weinmann-Menke, Johannes Gutenberg University Mainz, Germany, discuss the latest SLE Treatment Recommendations from the European League Against Rheumatism (EULAR), which detail advanced management and targeting remission as elevated treatment goals to improve patient outcomes.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.